Fig. 3From: Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agentsPlasma Concentration-time plots of imatinib in (a) C57BL/6 mice, (b) prairie dogs after a single intravenous or oral dose. Solid line represents IV administration and dotted line represents oral administrationBack to article page